The New York Stock Exchange trading floor. Photo Credit: Tobias Deml
On the heels of Universal Music’s latest stock buyback, Spotify has set aside a cool $1.5 billion to repurchase its own shares – for a planned overall capital deployment in excess of $2.2 billion when factoring for the remaining portion of an existing tranche.
Spotify (NYSE: SPOT) disclosed the supersized buyback plans today, days after Universal Music Group (UMG) confirmed dropping $160 million on its shares during a five-day stretch. While it probably goes without saying, the repurchase programs are coinciding with sagging stock prices.
But of the two, it’s UMG that’s encountering more turbulence on the public market, we noted earlier this week. At €14.90 (currently $17.41), the major’s stock price is down about 33% from 2026’s start and is well beneath its IPO positioning.
(It now seems safe to conclude that there was truth to the UMG investor frustrations highlighted by Bill Ackman during Pershing Square’s takeover attempt. Though Bolloré put the kibosh on said attempt, the major’s present market cap isn’t exactly indicative of confidence among the wider shareholder base.)
By contrast, Spotify stock is down 7.3% on the year (to $533 per share currently) and roughly 25% from late-August 2025, but is still up 150% or so from the same point in 2021.
Nevertheless, with Spotify execs having acknowledged the distinct possibility of a user-growth slowdown, the time is evidently right to scoop up even more shares – at least according to the board.
Given the $1.5 billion authorization and $723 million in undeployed capital, then, the DSP is poised to acquire $2.223 billion worth of SPOT. The timing here isn’t concrete, and the “actual number of shares repurchased will depend on a variety of factors,” Spotify emphasized for good measure.
Closer to the present, a quick look at analysts’ SPOT forecasts is in order. Overall, recent assessments appear bullish – to the tune of a whopping $685 target price from Bank of America and $640 from Morgan Stanley.
However, other financial professionals aren’t quite so enthusiastic. Barclays settled on a comparatively measured $565 target, against a bearish $420 from Pivotal Research, to name a couple examples.
As some will recognize, optimistic breakdowns don’t guarantee positive results on the market. To be sure, certain analysts have long been in the habit of setting sky-high targets, quickly slicing them in response to valuation decreases, and then opting for material upward adjustments as trends and sentiment permit – all while rehashing the same tired points in generic reports containing exceedingly little useful information.
Put differently, one would be wise to take industry stock forecasts – and full-sector reports projecting billions upon billions of dollars in near-term revenue growth from loosely defined sources, for that matter – with a grain of salt.